Research: Use of UK plasma for the manufacture of albumins and vCJD risk
Imported from official source
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
This version
- Version
- 1 of 1
- Recorded
- September 20, 2026 19:53
- Change
- Initial
- Content hash
6fcf794ada99800ccec512a2356fab9d- All versions
- Revision history